Evidence map›Paper›PMID 35980414›Full record

ArticleThe western journal of emergency medicine2022

Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions.

Timothy D Kelly, Kathryn F Hawk, Elizabeth A Samuels, Reuben J Strayer, Jason A Hoppe

Abstract read
In one paragraph

Article in The western journal of emergency medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. The Financial Sustainability of Programs to Initiate Medications for Opioid Use Disorder in Emergency Department Settings.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2026
    Article
  3. Racial, ethnic, and sex disparities in buprenorphine treatment from emergency departments by discharge diagnosis.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Timothy D KellyIndiana University Emergency Medicine Residency, Indianapolis, Indiana.
Kathryn F HawkYale School of Medicine, Department of Emergency Medicine, New Haven, Connecticut.
Elizabeth A SamuelsAlpert Medical School of Brown University, Department of Emergency Medicine, Providence, Rhode Island.
Reuben J StrayerMaimonides Medical Center, Department of Emergency Medicine, Brooklyn, New York.
Jason A HoppeUniversity of Colorado School of Medicine, Department of Emergency Medicine, Aurora, Colorado.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Emergency departments (ED) are increasingly providing buprenorphine to persons with opioid use disorder. Buprenorphine programs in the ED have strong support from public health leaders and emergency medicine specialty societies and have proven to be clinically effective, cost effective, and feasible. Even so, few ED buprenorphine programs currently exist. Given this imbalance between evidence-based practice and current practice, proven behavior change approaches can be used to guide local efforts to expand ED buprenorphine capacity. In this paper, we use the theory of planned behavior to identify and address the 1) clinician factors, 2) institutional factors, and 3) external factors surrounding ED buprenorphine implementation. By doing so, we seek to provide actionable and pragmatic recommendations to increase ED buprenorphine availability across different practice settings.

Indexed as

BuprenorphineEmergency MedicineOpioid-Related DisordersEmergency Service, HospitalHumansNarcotic AntagonistsOpiate Substitution TreatmentBuprenorphineNarcotic Antagonists

Identifiers

PMID35980414
PMCPMC9391022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.